- Home
- MIND vs CNTB Comparison
MIND vs CNTB Comparison
Compare MIND & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIND
- CNTB
- Stock Information
- Founded
- MIND 1987
- CNTB 2012
- Country
- MIND United States
- CNTB United States
- Employees
- MIND N/A
- CNTB N/A
- Industry
- MIND Industrial Machinery/Components
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- MIND Industrials
- CNTB Health Care
- Exchange
- MIND Nasdaq
- CNTB Nasdaq
- Market Cap
- MIND 49.6M
- CNTB 54.4M
- IPO Year
- MIND 1994
- CNTB 2021
- Fundamental
- Price
- MIND $10.50
- CNTB $1.70
- Analyst Decision
- MIND
- CNTB Strong Buy
- Analyst Count
- MIND 0
- CNTB 2
- Target Price
- MIND N/A
- CNTB $7.50
- AVG Volume (30 Days)
- MIND 235.3K
- CNTB 168.9K
- Earning Date
- MIND 09-10-2025
- CNTB 08-13-2025
- Dividend Yield
- MIND N/A
- CNTB N/A
- EPS Growth
- MIND N/A
- CNTB N/A
- EPS
- MIND 2.91
- CNTB N/A
- Revenue
- MIND $45,087,000.00
- CNTB $1,965,000.00
- Revenue This Year
- MIND $7.27
- CNTB N/A
- Revenue Next Year
- MIND N/A
- CNTB N/A
- P/E Ratio
- MIND $3.61
- CNTB N/A
- Revenue Growth
- MIND 26.68
- CNTB N/A
- 52 Week Low
- MIND $3.05
- CNTB $0.51
- 52 Week High
- MIND $11.10
- CNTB $2.86
- Technical
- Relative Strength Index (RSI)
- MIND 58.61
- CNTB 43.04
- Support Level
- MIND $9.27
- CNTB $1.77
- Resistance Level
- MIND $10.87
- CNTB $2.46
- Average True Range (ATR)
- MIND 0.64
- CNTB 0.27
- MACD
- MIND -0.02
- CNTB -0.08
- Stochastic Oscillator
- MIND 66.18
- CNTB 8.24
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.